Integrating cervical cancer screening and treatment into HIV care in Nigeria

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to improve cervical cancer screening and treatment among women living with HIV in Nigeria by integrating these services into existing HIV care programs. It employs a cluster randomized, hybrid type III trial design to compare the effectiveness of standard implementation strategies against enhanced strategies for cervical cancer care. The study seeks to address barriers to care and improve retention in treatment for women affected by both HIV and cervical cancer. By leveraging existing healthcare infrastructure, the study aims to enhance health outcomes for this vulnerable population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Women living with HIV

Exclusion Criteria:

\-

Where it's running

• UC San Diego
  La Jolla, California, United States Recruiting
• University of Nigeria, Nsukka
  Enugu, Enugu State, Nigeria Recruiting

Study contacts

• Principal investigator: Gregory Aarons, PhD — University of California, San Diego
• Study coordinator: Gregory Aarons, PhD
• Email: gaarons@health.ucsd.edu
• Phone: 858-966-7703

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• DeepDOF imaging for cervical tissue at point-of-care

  This study tests a new DeepDOF digital microscope to see if its cervical biopsy and LEEP images can match standard pathology in women with cervical lesions, including those living with HIV.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT06850402

• Cervical screening and care options for women living with HIV who test positive for high-risk HPV

  This study tests different ways to screen and manage high-risk HPV in women with HIV to see what might work best for them.

  Recruiting University of California, San Diego · Nairobi · NCT07925307

• Hydrogel spacer to protect the rectum during cervical cancer radiotherapy

  This study tests whether placing an absorbable hydrogel spacer between the cervix/vagina and rectum before definitive radiotherapy can reduce rectal radiation exposure for women with cervical cancer.

  Recruiting Tianjin Medical University Cancer Institute and Hospital · Tianjin, Tianjin Municipality · NCT07904182

• How cinema sessions during chemotherapy might help cervical cancer patients

  We’re testing if watching films during chemotherapy helps cervical cancer patients feel less anxious and improve quality of life.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma · NCT07902180

• One-Finger Technique to identify the left upper ureter during para-aortic lymphadenectomy

  This study tests a new surgical method to help surgeons find the left upper ureter during open para-aortic lymphadenectomy in women with gynecologic cancers.

  Recruiting Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Guangzhou, Guangdong · NCT07895212

• Radiotherapy for gynecologic cancer with up to 10 metastatic sites

  This registry follows adults with gynecologic cancer who have 1 to 10 active metastatic lesions and are treated with radiotherapy as part of routine care to see how such treatments work in real-world settings.

  Recruiting Affidea Nu-med Center of Oncological DIagnostics and Therapy · Zamość · NCT07883798

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.